Bobak Parang Receives Rising Tide/LUNGevity Research Award
The award supports research into overcoming drug resistance in EG, with an investment of more than $600,000.
Related stories
Cann Group Posts Q1 Revenue of A$3.45 Million
M impact | EQUITY | Oct 30, 2026, 12:57 AM UTC
Civmec shares rise on upbeat quarterly results
Civmec shares rose on upbeat quarterly results.
M impact | EQUITY | Oct 30, 2026, 12:55 AM UTC
Hyundai Mobis Q3 Operating Profit Rises 17.15% Year on Year
M impact | EQUITY | Oct 30, 2026, 12:54 AM UTC
Firstwave Cloud Technology Reports Quarterly Revenue of A$1.90M
M impact | EQUITY | Oct 30, 2026, 12:54 AM UTC
Amazon Shares Fall 7% After Q3 Results Show Weaker Free Cash Flow
Amazon shares fell more than 7% in extended trading after third-quarter results missed expectations, fourth-quarter revenue guidance midpoint trailed projections and free cash flow
M impact | EQUITY | Oct 30, 2026, 12:51 AM UTC
Japan's Nikkei average falls 2%
M impact | EQUITY | Oct 30, 2026, 12:50 AM UTC